Anti-rheumatics drug market accounted for $57 billion in sales in 2018 and is expected to reach nearly $72 billion by 2026, registering a CAGR of 2.9% from 2019 to 2026. https://t.co/X77cx5QM4G https://t.co/eNCvemksWK